Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis

S G Chu1, R C Becker, P B Berger

  • 1University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Abstract

Insights

Elevated mean platelet volume (MPV) is linked to acute myocardial infarction (AMI) and increased mortality risk after heart attack. Higher MPV also correlates with restenosis after angioplasty, suggesting its potential as a prognostic biomarker in cardiovascular disease.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarker Research

Background:

  • Platelet activity plays a key role in atherothrombotic events.
  • Mean platelet volume (MPV) is a readily available clinical measure reflecting platelet activation.
  • MPV's association with cardiovascular disease warrants further investigation.

Purpose of the Study:

  • To investigate the association between mean platelet volume (MPV) and acute myocardial infarction (AMI).
  • To examine the relationship between MPV and cardiovascular outcomes, including mortality post-MI and restenosis after coronary angioplasty.

Main Methods:

  • A systematic review and meta-analysis was conducted.
  • Data from cross-sectional and cohort studies were pooled using random-effects modeling.
  • Studies investigated MPV in relation to AMI, all-cause mortality after MI, and restenosis post-coronary angioplasty.

Main Results:

  • MPV was significantly higher in patients with AMI compared to controls (mean difference 0.92 fL).
  • Elevated MPV was associated with increased odds of death following myocardial infarction (OR 1.65).
  • Higher MPV was observed in patients who developed restenosis after coronary angioplasty (mean difference 0.98 fL).

Conclusions:

  • Elevated MPV is associated with acute myocardial infarction, post-MI mortality, and restenosis.
  • MPV may serve as a prognostic biomarker in patients with cardiovascular disease.
  • The causal nature of this association and its therapeutic implications require further study.

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...